NASDAQ:ADIL | Cash Flow Statement | ADIAL PHARMACEUTICALS, INC.

Complete source-backed cash-flow history.

Available history
2017-06-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$51.99M
2026-03-31-$2.02M-$1.61M$315,284.00
2025-12-31-$2M-$1.32M$0.00$2.6M
2025-09-30-$1.79M
2025-06-30-$1.96M
2025-03-31-$2.23M-$1.59M$150,000.00$50,648.00
2024-12-31-$2.07M-$1.45M$0.00
2024-09-30-$2.19M
2024-06-30-$2.46M
2024-03-31-$6.48M-$1.63M$3.82M
2023-12-31-$1.92M-$1.22M$350,000.00$0.00$3.38M
2023-09-30-$1.38M
2023-06-30$1.09M
2023-03-31-$2.91M-$2.3M$609,613.00
2022-12-31-$2.87M-$1.75M$0.00
2022-09-30-$3.11M
2022-06-30-$3.85M
2022-03-31-$2.91M-$2.5M$9.12M
2021-12-31-$5.83M-$2.37M$0.00$0.00$1.25M
2021-09-30-$4.32M
2021-06-30-$4.44M
2021-03-31-$4.83M-$2.84M$30,875.00-$286.00$4.08M
2020-12-31-$3.47M-$2.61M$0.00
2020-09-30-$3.34M
2020-06-30-$1.81M
2020-03-31-$2.28M-$1.83M
2019-12-31-$2.06M-$1.75M$109.00
2019-09-30-$1.72M
2019-06-30-$2.13M
2019-03-31-$2.68M-$1.72M$9.25M
2018-12-31-$1.27M-$1.1M$156,250.00
2018-09-30-$8.19M
2018-06-30-$1.79M
2018-03-31-$378,950.00-$214,282.00$250,001.00
2017-12-31-$403,992.00-$122,102.00$0.00$100,000.00
2017-09-30-$292,626.00
2017-06-30-$264,273.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$7.98M-$6.49M$150,000.00$8.47M
2024-12-31-$13.2M-$6.92M$7.85M
2023-12-31-$5.12M-$6.81M$1.5M$1,661.00$4.13M
2022-12-31-$12.73M-$11.19M$9.13M
2021-12-31-$19.42M-$11.95M$64,605.00-$34,016.00$13.64M
2020-12-31-$10.89M-$7.63M-$350,000.00$5.61M
2019-12-31-$8.59M-$6.34M$9.25M
2018-12-31-$11.63M-$2.5M$6.35M
2017-12-31-$1.14M-$494,862.00$35,117.00$390,000.00